Alcohol intake and markers of liver health in patients with type 2 diabetes and metabolic dysfunction–associated steatotic liver disease

Key Points

• The study aimed to assess how low-level alcohol consumption affects liver health in individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.
• Evaluated liver health markers in patients with type 2 diabetes and MASLD
• Assessed the impact of low-level alcohol intake
• Utilized biochemical analyses to measure liver function
• Lower alcohol intake associated with improved liver markers
• 80% of participants showed significant reduction in liver enzymes
• Increased adherence to low alcohol consumption guidelines correlated with better liver health outcomes